Transcriptome analysis reveals molecular profiles associated with evolving steps of monoclonal gammopathies.
about
High throughput chemical library screening identifies a novel p110-δ inhibitor that potentiates the anti-myeloma effect of bortezomibThe ubiquitin-conjugating enzyme UBE2O modulates c-Maf stability and induces myeloma cell apoptosisCharacterization of monoclonal gammopathy of undetermined significance by calorimetric analysis of blood serum proteome.Recurrent mutations of MAPK pathway genes in multiple myeloma but not in amyloid light-chain amyloidosis.Management of asymptomatic myeloma patients.Selective inhibition of matrix metalloproteinase-2 in the multiple myeloma-bone microenvironmentClass IIa HDAC inhibition enhances ER stress-mediated cell death in multiple myeloma.Distinct lncRNA transcriptional fingerprints characterize progressive stages of multiple myeloma.Targeting the Bone Marrow Microenvironment.MGUS to myeloma: a mysterious gammopathy of underexplored significance.A gene expression inflammatory signature specifically predicts multiple myeloma evolution and patients survival.The transcriptional profiling of human in vivo-generated plasma cells identifies selective imbalances in monoclonal gammopathiesGene Expression Profiles in Myeloma: Ready for the Real World?The small GTPase RhoU lays downstream of JAK/STAT signaling and mediates cell migration in multiple myeloma.Targeting the MALAT1/PARP1/LIG3 complex induces DNA damage and apoptosis in multiple myeloma.Germline mutations in lysine specific demethylase 1 (LSD1/KDM1A) confer susceptibility to multiple myeloma.Membrane translocation of Bruton kinase in multiple myeloma cells is associated with osteoclastogenic phenotype in bone metastatic lesions.In silico analysis identifies CRISP3 as a potential peripheral blood biomarker for multiple myeloma: From data modeling to validation with RT-PCR.A multiple myeloma classification system that associates normal B-cell subset phenotypes with prognosisMALDI-TOF analysis of blood serum proteome can predict the presence of monoclonal gammopathy of undetermined significance
P2860
Q28818948-D80FB63E-B8F0-42F2-8CEC-E0A515D94454Q33869569-3F84A8AD-79D9-4D4B-B2BF-ECC72612B451Q35202780-D199268D-2F83-4B70-B2EC-8F1D012AF6CCQ37708798-C9D5D2D7-1633-439F-AB7C-5FDB35ED637FQ38264322-6E5E078A-E841-48E0-B926-23E76E193EABQ38726989-BE031D78-9270-4C47-97A8-7CA3FCA3657BQ38895976-A10E0245-0990-465B-80ED-5282B66FA5EFQ38905792-575E1B74-3A7A-47E0-9A6F-8A1CAC6BA2CEQ38970585-4503EA68-71E3-41A7-ADBC-EB32A715517BQ38979865-D5437A56-B0A0-4D87-8B34-E6ACC7DE8CFFQ41091865-C2A73D3B-3424-4E73-BB60-7E96CBCDA831Q41444022-FCE618FB-7EEA-4AB6-BC34-141B4C98AFEBQ43847809-62243663-7300-41F1-883A-31476052F12FQ49872152-96216D90-D0F9-452F-8740-B00DAA80BC63Q52327430-2C6028EE-0E1F-4A77-8E99-2BDBED39236CQ52646188-58E118DF-24F0-4DA9-BF9C-F0C74BFABECEQ54983552-3B3EECB0-ABA6-4EA6-8992-04CB00521C0DQ55283436-A1A74747-D3ED-42D9-A50D-100FA3E99DB3Q58698408-DB1BBFCF-D799-4ABC-AB61-D37932E4C777Q58803709-1ED3AAE9-83E1-47D3-9457-8D50D51F266E
P2860
Transcriptome analysis reveals molecular profiles associated with evolving steps of monoclonal gammopathies.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Transcriptome analysis reveals ...... ps of monoclonal gammopathies.
@ast
Transcriptome analysis reveals ...... ps of monoclonal gammopathies.
@en
type
label
Transcriptome analysis reveals ...... ps of monoclonal gammopathies.
@ast
Transcriptome analysis reveals ...... ps of monoclonal gammopathies.
@en
prefLabel
Transcriptome analysis reveals ...... ps of monoclonal gammopathies.
@ast
Transcriptome analysis reveals ...... ps of monoclonal gammopathies.
@en
P2093
P2860
P50
P1433
P1476
Transcriptome analysis reveals ...... eps of monoclonal gammopathies
@en
P2093
Ana Isabel Teruel
Encarna Fermiñán
Francisco Javier Burguillo
Joan Bladé
José Hernández
Juan-José Lahuerta
Lucía López-Corral
María Luz Martino
María Victoria Mateos
P2860
P304
P356
10.3324/HAEMATOL.2013.087809
P50
P577
2014-05-09T00:00:00Z